Cash is King – everyone is undoubtedly familiar with this saying. But did you know it rings true for corporations? Especially in today’s volatile economic climate, having a strong cash position is of paramount importance. In this piece, we spotlight five companies that boast strong cash balances: Sheng Siong Group Ltd (SGX: OV8), Wee Hur Holdings Ltd (SGX: E3B), Propnex Ltd (SGX: OYY), Raffles Medical Group Ltd (SGX: BSL), and Riverstone Holdings Ltd (SGX: AP4).What Defines a “Cash-Rich, Rock-Solid” Company ...

Core Viewpoint - A class action lawsuit has been filed against Agilon Health, Inc. for alleged violations of securities laws, specifically related to misleading statements made by the company regarding its financial guidance and strategic actions [1][4]. Group 1: Lawsuit Details - The lawsuit is based on violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [1]. - Investors who purchased Agilon's securities between February 26, 2025, and August 4, 2025, are encouraged to participate in the lawsuit [2]. - The class has not yet been certified, meaning potential participants are not currently represented by an attorney [3]. Group 2: Allegations Against Agilon - The complaint alleges that Agilon made false and misleading statements to the market, particularly regarding its 2026 guidance, which was deemed unrealistic [4]. - The company is accused of overstating the effectiveness of its strategic actions aimed at reducing risk, leading to materially misleading public statements throughout the class period [4]. - As a result of the revelations about Agilon's true situation, investors reportedly suffered financial damages [4].

CVS Health Corporation (NYSE:CVS) is included among the 20 Best Performing Dividend Stocks in 2025. JPMorgan Names CVS a Top Pick as Turnaround Gains Traction The stock dropped 43% in 2024, then swung the other way with an 80.5% gain this year. Even after that run, Wall Street still sees room to move. The average analyst price target points to another 19% upside.Earlier in December, JPMorgan named CVS Health Corporation (NYSE:CVS) as a top pick in health care services. “We remain positive on CVS post-Inv ...

Core Insights - Evolent Health, Inc. has granted a one-time time-based restricted stock unit award of 587,500 shares to its new Chief Financial Officer, Mr. Mario Ramos, as an inducement for his employment with the company [1] - The total grant date value of the Inducement Award is $2,350,000, with vesting scheduled over three years contingent on Mr. Ramos's continued employment [2] Company Overview - Evolent specializes in improving health outcomes for individuals with complex conditions by providing solutions that simplify and make healthcare more affordable [3] - The company serves a national base of leading payers and providers and is recognized as a top workplace in the healthcare sector [3]

Jan. 2 marked the first trading session of 2026 for the U.S. stock market. And Bitcoin-treasury stock Kindly MD (NASDAQ: NAKA) is trading higher despite ongoing regulatory scrutiny. The rally follows a challenging few weeks for the healthcare-turned-crypto firm, which recently received a delisting notice from Nasdaq. Related: 'Alarming' growth of bitcoin treasuries prompts all-time high price prediction What is Kindly MD? Kindly MD, Inc. is a healthcare and healthcare data company that provides direct ...

Core Insights - CVS Health achieved a remarkable 58% gain, marking its best performance since 1982 [1] Company Performance - CVS Health's significant growth reflects a broader trend of strong performance among other companies in the sector [1]

Core Insights - Nova Leap Health Corp. has promoted Melissa Anderson to Senior Vice President (U.S.) effective January 1, 2026, recognizing her contributions to the company's U.S. operations since joining in 2018 [1][2][3] Company Overview - Nova Leap is a healthcare services company focused on home-based and community-based care across North America, providing personal care, dementia care, and companion services [4] - The company has launched a Care Management division to offer coordinated, technology-enabled support for families navigating complex medical, cognitive, and social needs [4] Leadership and Growth Strategy - Melissa Anderson's promotion reflects her strong performance and the increasing complexity of Nova Leap's U.S. business, which is expanding through new locations, acquisitions, and additional service lines [2][3] - The company is committed to disciplined growth, including targeted acquisitions and de novo expansion supported by scalable infrastructure [3][4]

美国流感季疫情加剧，新毒株出现或导致疫苗防护效果下降，新冠病例则持续处于低位。 ▸ 核心提要 美国流感确诊病例连日走高，疾控部门担忧当前流感疫苗对流行的新毒株防护效果不足。公共卫生专家 表示，本轮流感季虽已进入高发期，但尚未达峰值，病例激增符合往年流感季的流行规律，疫苗仍能有 效降低重症风险。新冠疫情则持续缓和，污水监测数据显示病毒传播水平远低于夏季峰值。 文 / 戴维・奥瓦列 美国流感确诊病例呈上升趋势，主导疫情的是一种新型流感毒株，公共卫生部门担忧现有疫苗无法对其 形成有效防护。 卫生官员与研究人员指出，尽管本轮流感季尚未迎来峰值，此次病例激增并非历史罕见情况，同时强调 疫苗大概率仍能抵御该毒株引发的重症风险。 美国疾控中心数据显示，流感相关的住院、急诊、门诊就诊人次及死亡病例均大幅上升，不过美国流感 疫情峰值预计要到明年初才会到来，大概率在 2 月。 布朗大学公共卫生学院大流行病研究中心主任、流行病学家詹妮弗・努佐表示："本轮流感病例增长虽 略显迅猛，但实属正常。流感季的疫情传播向来来势汹汹。" 冬季的环境条件极易助长流感、新冠、呼吸道合胞病毒等空气传播类病毒的扩散，民众长期聚集在室 内、节假日出行增多 ...

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of agilon health, inc. securities between February 26, 2025, and August 4, 2025, due to alleged misleading statements and guidance by the company [1][5]. Group 1: Lawsuit Details - The lawsuit claims that defendants made false and/or misleading statements regarding agilon's financial guidance for 2025, which they knew was unattainable due to industry challenges [5]. - It is alleged that the defendants overstated the positive financial impact from strategic actions taken by agilon to mitigate risks, leading to materially false statements about the company's business and prospects [5]. - Investors are encouraged to join the class action without incurring out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Participation Information - Interested parties can join the agilon class action by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must file a motion with the court by March 2, 2026, to represent other class members in the litigation [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its success in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4].

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who acquired Agilon Health, Inc. (NYSE: AGL) securities between February 26, 2025, and August 4, 2025, alleging that the company misled investors regarding its business prospects [1] Allegations - The complaint asserts that Agilon Health, Inc. failed to disclose that it issued guidance for 2025 that was unrealistic, given the material industry challenges they were aware of, and that they materially overstated the financial benefits from strategic actions taken to mitigate risks [2] Company Developments - On August 4, 2025, Agilon announced the resignation of Steven Sell as President, CEO, and Director, stating that his departure was a termination without 'cause' according to his employment agreement. The same day, the company released disappointing financial results, leading to a stock price drop of over 50%, closing at $0.8801 on August 5, 2025 [3] Class Action Participation - Shareholders may be eligible to participate in the class action against Agilon Health, Inc. Those interested in serving as lead plaintiffs should contact Robbins LLP. Participation is not required to be eligible for recovery, and shareholders can choose to remain absent class members [4]